US FDA refuses to approve Merck's Zetia and Vytorin medicines
The US Food and Drug Administration (FDA) has refused to approve Zetia and Vytorin, Merck's medicines that are used to reduce the risk of cardiovascular events in patients with coronary heart disease.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Cardiovascular | Coronary Heart Disease | Food and Drug Administration (FDA) | Heart | Heart Disease | Merck | Pharmaceuticals | Vytorin | Zetia